These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23256431)

  • 1. Scleritis--Wegener's granulomatosis.
    Opremcak EM
    Insight; 2012; 37(4):13. PubMed ID: 23256431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe Wegener's granulomatosis successfully treated with rituximab].
    Semenkova EN; Krivosheev OG; Novikov PI; Osipenko VI; Nosova NR; Parfenova SA; Nikiforova NV; Borodin OO
    Ter Arkh; 2010; 82(6):53-5. PubMed ID: 20731113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case of acute, resistant fulminant Wegener's granulomatosis successfully treated by rituximab.
    Ebrahim AK; Loock JW
    J Laryngol Otol; 2013 Apr; 127(4):411-4. PubMed ID: 23480661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.
    Kontkanen M; Paimela L; Kaarniranta K
    Acta Ophthalmol; 2010 May; 88(3):e96-7. PubMed ID: 19758399
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-TNF alpha therapy in chronic necrotizing scleritis resistant to standard immunomodulatory therapy in a patient with Wegener's granulomatosis.
    El-Shabrawi Y; Hermann J
    Eye (Lond); 2005 Sep; 19(9):1017-8. PubMed ID: 15389262
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis.
    Onal S; Kazokoglu H; Koc A; Yavuz S
    Ocul Immunol Inflamm; 2008; 16(5):230-2. PubMed ID: 19065418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab.
    Staines KS; Higgins B
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):76-80. PubMed ID: 19451001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
    Novikov PI; Krivosheev OG; Semenkova EN
    Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.
    Cheung CM; Murray PI; Savage CO
    Br J Ophthalmol; 2005 Nov; 89(11):1542. PubMed ID: 16234479
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subglottal stenosis as the first symptom of Wegener's granulomatosis].
    Verhaegen VJ; Rongen GA; Marres HA
    Ned Tijdschr Geneeskd; 2007 May; 151(19):1087-90. PubMed ID: 17552419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis.
    Freidlin J; Wong IG; Acharya N
    Br J Ophthalmol; 2007 Oct; 91(10):1414. PubMed ID: 17895422
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed presentation of Wegener's granulomatosis with pancreatic involvement.
    Hamilton L; Gaffney K; Andreou A; Saada J
    Int J Rheum Dis; 2011 Oct; 14(4):e54-5. PubMed ID: 22004241
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.
    Holle JU; Dubrau C; Herlyn K; Heller M; Ambrosch P; Noelle B; Reinhold-Keller E; Gross WL
    Ann Rheum Dis; 2012 Mar; 71(3):327-33. PubMed ID: 22021864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab therapy for refractory idiopathic scleritis.
    Bogdanic-Werner K; Fernandez-Sanz G; Alejandre Alba N; Ferrer Soldevila P; Romero-Bueno FI; Sanchez-Pernaute O
    Ocul Immunol Inflamm; 2013 Aug; 21(4):329-32. PubMed ID: 23662782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wegener's granulomatosis with massive skin necrosis.
    Cybulska A; Undas A; Sydor WJ; Flak A; Musial A
    J Rheumatol; 2004 Apr; 31(4):830-1. PubMed ID: 15095749
    [No Abstract]   [Full Text] [Related]  

  • 19. Nasal ulcers in the ED: from Wegener's granulomatosis.
    Johnson R; Crisham M
    Am J Emerg Med; 2005 Oct; 23(6):817-9. PubMed ID: 16182998
    [No Abstract]   [Full Text] [Related]  

  • 20. [Wegener's granulomatosis: ocular manifestations, diagnosis and therapy].
    Duncker G; Beigel A; Lehmann H
    Klin Monbl Augenheilkd; 1982 Sep; 181(3):184-7. PubMed ID: 7144012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.